Currently, Elanco Animal Health Inc [ELAN] is trading at $15.47, up 1.18%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ELAN shares have gain 6.18% over the last week, with a monthly amount glided 18.63%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Elanco Animal Health Inc [NYSE: ELAN] stock has seen the most recent analyst activity on January 05, 2024, when Stifel upgraded its rating to a Buy and also boosted its price target to $20 from $13. Previously, Jefferies started tracking the stock with Buy rating on December 19, 2023, and set its price target to $17. On December 15, 2023, upgrade upgraded it’s rating to Overweight but maintained its price target of $16 on the stock. Exane BNP Paribas started tracking the stock assigning a Outperform rating and suggested a price target of $18 on December 07, 2023. Barclays upgraded its rating to a Overweight but $14 remained the price target by the analyst firm on April 20, 2023. Morgan Stanley downgraded its rating to Equal-Weight for this stock on August 18, 2022, and downed its price target to $22. In a note dated August 16, 2022, JP Morgan downgraded an Neutral rating on this stock and revised its target price from $28 to $24.
This stock has fluctuated between a low of $8.52 and a high of $18.80 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $25.83 within the next 12 months. Elanco Animal Health Inc [NYSE: ELAN] shares were valued at $15.47 at the most recent close of the market. An investor can expect a potential return of 66.97% based on the average ELAN price forecast.
Analyzing the ELAN fundamentals
Trailing Twelve Months sales for Elanco Animal Health Inc [NYSE:ELAN] were 4.49B which represents 12.02% growth. Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at -0.28%, and Net Profit Margin reading is -0.28%. To continue investigating profitability, this company’s Return on Assets is posted at -0.09, Equity is -0.21 and Total Capital is 0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.96.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.25 points at the first support level, and at 15.02 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.70, and for the 2nd resistance point, it is at 15.92.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Elanco Animal Health Inc [NYSE:ELAN] is 2.93. In addition, the Quick Ratio stands at 1.75 and the Cash Ratio stands at 0.3. Considering the valuation of this stock, the price to sales ratio is 1.70, the price to book ratio is 1.29.
Transactions by insiders
Recent insider trading involved Harrington Michael J, Director, that happened on Aug 22 ’24 when 3500.0 shares were purchased. PRESIDENT, CEO AND DIRECTOR, Simmons Jeffrey N completed a deal on Aug 12 ’24 to buy 100000.0 shares. Meanwhile, Director DOYLE WILLIAM F bought 15000.0 shares on May 21 ’24.
